Wells Fargo
TCRX icon

Wells Fargo’s TScan Therapeutics TCRX Stock Holding History

Wells Fargo’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-323
Closed -$468 – 7397
2025
Q2 		$468 Sell
323
-19,892
-98% -$28.7K ﹤0.01% 6378
2025
Q1 		$27.9K Buy
20,215
+675
+3% +$1.46K ﹤0.01% 5598
2024
Q4 		$59.4K Buy
19,540
+5,694
+41% +$25.8K ﹤0.01% 5420
2024
Q3 		$69K Sell
13,846
-40
-0.3% -$241 ﹤0.01% 5215
2024
Q2 		$81.2K Buy
13,886
+13,580
+4,438% +$107K ﹤0.01% 5064
2024
Q1 		$2.43K Buy
306
+5
+2% +$31 ﹤0.01% 5995
2023
Q4 		$1.75K Buy
301
+15
+5% +$69 ﹤0.01% 6124
2023
Q3 		$732 Buy
286
+206
+258% +$481 ﹤0.01% 6272
2023
Q2 		$200 Buy
80
+5
+7% +$13 ﹤0.01% 6706
2023
Q1 		$158 Buy
75
+2
+3% +$5 ﹤0.01% 6835
2022
Q4 		$113 Buy
73
+1
+1% +$2 ﹤0.01% 6766
2022
Q3 		$0 Buy
72
+26
+57% +$85 ﹤0.01% 7410
2022
Q2 		$0 Buy
46
+5
+12% +$14 ﹤0.01% 7532
2022
Q1 		$0 Hold
41
– – ﹤0.01% 7845
2021
Q4 		$0 Hold
41
– – ﹤0.01% 7834
2021
Q3 		$0 Buy
+41
New +$380 ﹤0.01% 7546

Other funds holding TCRX

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $6.49B AUM 10.69% 1-Year Est. Return